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Nanomedicine is the application of nanotechnology in treat-
ment, diagnosis, monitoring and control of biological sys-
tems, and is at the leading-edge of clinical medicine and 
preclinical research. Increasing attention has been paid to 
the application of nanotechnology in medicine recently 
(Figure 1). Nanotechnology means the control of matter and 
processes at a nanoscale (1–100 nm) in one or more dimen-
sions [1]. The material and devices operated at the nanoscale 
usually have different physical properties compared with 
those at the normal size. Nanomedicine-based approaches 
have thus an unprecedented potential to better control bio-
logical processes and to improve the detection, therapy and 
prevention of multiple diseases. The applications of nano-
technology and its safety have become the highlight of cur-
rent biomedical research. This paper focuses on the main 
nanotechnologies and their biosafety encountered in bio-
medical research, diagnosis and therapy (Figure 2).  
1  Nanotechnology in biomedical analysis and 
research 
Fluorescence imaging has been widely used in biology and 
medicine. Single-molecule detection (SMD) can detect sig-
nals from individual molecules, which removes the average 
effect in classical ensemble experiments [2,3]. Besides the 
confocal fluorescence microscopy, the main SMD tech-
niques include total internal reflection fluorescence micros-
copy (TIRFM), single-molecule fluorescence resonance 
energy transfer (smFRET), cylindrical illumination confocal  
 
Figure 1  The publication amounts of nanomedicine related papers in 
PubMed in the last 10 years. 
spectroscopy (CICS), epi-fluorescence microscopy, confo-
cal microscopy, quasi-TIRFM and single-point edge excita-
tion subdiffraction microscopy (SPEED). SMD techniques 
are widely used in membrane protein research. For instance, 
in the experiment regarding TGF-beta type II receptors of 
neonatal rat cardiomyocytes, the dimerized receptors were 
found to increase in hypertrophic cardiomyocytes by SMD 
[4], which infers the functioning of TGF-beta signaling in 
cardiac remodeling. Another study tracked the 1A-adren-      
ergic receptor, and found that endocytic pathway is in-
volved in 1A-AR-induced ERK1/2 activation, and is inde-
pendent of G(q)/PLC/PKC signaling [5]. Moreover, some 
nanomaterials are potential florescence probes in relevant 
technologies. For instance, quantum dots are of high photo 
stability, high identification accuracy and controllable col-
ors, and have been used as fluorescence imaging probes, 
fluorescent protein FRET probes and molecular beacons [6]. 
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Figure 2  The nanotechnology in the biomedical research and the applica-
tion of nanomaterial in the diagnosis and therapy of diseases.  
Atomic force microscopy (AFM) is a powerful tool in the 
study of biomolecular interactions, and can measure the 
binding forces at the molecular level of protein/DNA, DNA/ 
DNA, ligand/receptor and other biomolecule pairs. It is 
based on the nanomechanical cantilever sensors and micro-
cantilever-based biosensors, which can provide rapid and 
sensitive in situ detection [7]. AFM has been used to study 
the influences of substrate stiffness on mechanical proper-
ties of cardiac myocytes and fibroblasts [8]. Cardiac fibro-
blasts, but not myocytes, displayed the non-monotonic de-
pendence on substrate stiffness with a maximum elastic 
modulus, which was further found to be regulated by actin 
filaments. The nanoscale architecture of microbes and the 
mechanic properties of viruses can also be detected by the 
AFM [9,10]. Moreover, The AFM is an optimal choice to 
determine the structure, conformational changes and dy-
namics of membrane proteins under near-physiological con-
ditions, so as to investigate the cell communication, signal 
transduction, etc. [11].  
2  Nanotechnology in diagnosis  
Nanomaterials have been used in diagnosis mostly as con-
trast agent in molecular imaging. They are usually in small 
size and of much higher surface area to volume ratio, thus 
their surface can be decorated with more therapeutic mole-
cules, imaging agents, targeting ligands, and nucleic acids. 
When used as contrast agents, they can circulate in the 
blood for longer time with higher sensitivity and possibly 
fewer side-effects [1]. X-ray computed tomography (CT) is 
widely used in diagnostic medicine. Many kinds of nano-
materials have shown great potentials as CT contrast agents, 
such as gold, silver, bismuth, and tantalum nanomaterials 
[6]. Gold nanoparticles have higher atomic number, X-ray 
absorption coefficient, and longer blood circulation half-life 
than clinically used CT contrast agents [6]. They are also 
utilized in light scattering imaging, two-photon fluorescence 
(TPF) imaging and photoacoustic imaging in the cell imag-
ing-based detection for tumors [12]. Besides, entrapment 
with Liposomes can prolong the circulation half-time of 
traditional contrast agents as iodinated ones [6].  
Magnetic resonance imaging (MRI) provides superior 
contrast in soft tissue imaging and has no radiation. Com-
pared with gadolinium-based MRI contrast agents, nanopar-
ticle MRI contrast agents circulate longer in the blood, and 
have higher sensitivity and fewer side-effects [6]. Combin-
ing positron emission tomography (PET) with the high- 
resolution, spectroscopic, and contrast enhancement abili-
ties of MRI would make a breakthrough in the detection and 
monitoring of diseases. Superparamagnetic iron oxide na-
noparticles (SPIONs) are the most promising nanoparticle 
system as MRI and PET contrast agents [6,13]. These nano-
crystals containing thousands of Fe atoms can generate sig-
nal contrast with several orders of magnitude higher than a 
gadolinium chelate. A variety of SPIONs have been synthe-
sized with differences in the formation of cores and surface 
coating, and many of them are currently under clinical trials 
[14,15].  
3  Nanotechnology in therapy 
Nanomaterials have been introduced to the therapy of mul-
tiple diseases, including drug delivery system and nano- 
drugs. Drug delivery is one of the typical applications of 
nanomaterials in medicine. For example, tumor targeting, 
imaging and drug delivery can be accomplished by admin-
istrated gold nanoparticles and nanorods, iron oxide nan-
oworms and drug loaded liposomes [6,12]. Some other na-
nomaterials can be used to decorate gold nanoparticles to 
improve the capability [16]. The nanotechnology has also 
been applied to the intelligent drug-delivery systems [17] 
and implantable drug-delivery systems [18,19], so as to re-
alize the controlled and targeted release of therapeutic drugs. 
Besides drug delivery, nanomaterials have been adopted in 
some specific tumor therapies. Au nanoparticles have the 
potential to be developed as novel contrast agents in photo-
thermal cancer therapy [20]. They concentrate in the dis-
eased region, absorb light and convert it into heat to destroy 
the malignant cells. Gd@C82(OH)22 nanoparticles have been 
demonstrated to be a potent antitumor nanomedicine acting 
on the tumor microenvironment [1]. They have no direct 
tumor cytotoxicity, and their antineoplastic activity is based 
on the inhibition of oxidation stress and angiogenesis, the 
activation of immune reaction, the imprisoning of cancer 
cells, and the reversing of drug-resistance combination. Au 
nanoparticles have similar impact on tumor microenviron-
ment [12].  
The application of nanotechnology has opened a new 
realm in the advance of regenerative medicine. The devel-
opment of nanotechnology offers more opportunities of 
applying stem cells in the regeneration of tissues and organs. 
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Rebuilding tissue-like structures in vitro is important for 
both fundamental cell biology research and tissue engineer-
ing (TE). The top-down or bottom-up approach is adopted 
in TE [21,22]. The top-down approach is mainly seeding 
cells into the biomaterial scaffolds and forming similar 
macroscopic tissue features. The bottom-up approach fo-
cuses on the functional microscale features with physical 
and/or chemical methods. Microscale methods of the bot-
tom-up approach allow cells to form three-dimensional mi-
crostructures, and recapitulate the extracellular microenvi-
ronment around the cells for engineering microtissue con-
structs. A variety of nanomaterials are employed in regen-
erative medicine. Iron oxides like inorganic nanoparticles 
are among the most promising candidates in stem-cell re-
generation [22]. Titanium oxide (TiO2) surface nanostruc-
tures were reported to be utilized in orthopedic implant [23]. 
TiO2 nanotube exerts important impacts on osteogenic cells, 
and is promising in the orthopedic material surface designs.  
4  The biosafety of nanotechnology 
Biosafety is mostly concerned in nanotechnological appli-
cations. It is important to better understanding the metabolic 
fate and biological effect in cells or organs as increasing 
nanomaterials are hopeful materials to be applied in medi-
cine. The toxicity of most nanomaterials applied in biomed-
icine has been examined in preclinical research in that the 
low toxicity and optimal biocompatibility are necessary for 
their clinical applications. Gd@C82(OH)22 nanoparticles have 
no discernible toxic effects either in vitro or in vivo [24]. 
Carbon nanotubes (CNTs) are nanomaterials widely applied 
in biomedicine. However, the high cytotoxicity limits their 
use in humans. Water-soluble single-walled carbon nano-
tubes and fullerene C70(C(COOH)2)48 exerted more serious 
adverse effects on BY-2 cells [25]. Gold nanoparticles are 
considered to be relatively safe as elemental Au is highly 
inert. However, some study found it was hazardous in some 
cases [26]. However, those undesired side effects can be 
avoided by simply changing the capping agents. The func-
tionalization of CNTs can improve their solubility and bio-
compatibility, and change the interaction with cells, result-
ing in reduced cytotoxicity [27]. 
The cell uptake and metabolic fate of nanomaterials were 
also studied. The cellular uptake of nanoparticles depended 
on the time of incubation and the concentration of nanopar-
ticles in the medium [28,29]. Up-taken CNTs are shown to 
traffic through the different cellular barriers by ener-
gy-independent mechanisms [30]. SPIONs entered cells 
through multiple endocytic pathways and could be subse-
quently passaged to daughter cells, degraded in the lyso-
some, or exocytosed out of the cells [1]. In this process, 
SPIONs did not induce cell damage, except for the effect on 
iron metabolism. Better understanding of the nanomaterial 
metabolic pathways will contribute to the development of  
Table 1  Typical applications of nanotechnology in biomedical detection 
and in diagnosis and therapy 
Biomedical detection Diagnosis and therapy 
Bio-detection of pathogens  Tissue engineering 
Detection of proteins Photothermal therapy 
Detection of proteins MRI and CT contrast agents 
Probing of DNA structure Contrast enhancement 
Tissue engineering Drug and gene delivery 
Separation of biomolecules and cells Vaccination applications 
Fluorescent biological markers Nanorobotics 
Phagokinetic studies  




nanobiology and advocate the secure use of nanotechonol-
ogy in medicine.  
Nanoparticle toxicity is routinely assessed in cultured 
cells in vitro. The data from these studies require verifica-
tion from animal experiments, as they could be inconsistent 
and misleading [31]. Thus it is important to clarify the reli-
ability of cell nanoparticle toxicity assessment. Whether the 
excessive subculture could disturb the response of cultured 
cells to nanoparticles was studied, so as to obtain consistent 
toxicity test results. The investigators compared the cellular 
responses to silver nanoparticles across multiple passage 
numbers in Ba/F3-BCR-ABL cells [32]. The action of cul-
ture was not found to affect the cell response if the cultured 
cells were maintained in optimal state. Thus, it is suggested 
that cells isolated from normal tissues should be applied in 
the study of nanomaterials exposure on cells.  
It is highly promising that nanotechnologies be applied in 
biomedicine (Table 1). Nanomaterial-based contrast agents 
in molecular imaging usually have higher sensitivity and 
possibly fewer side-effects, and can circulate in the blood 
for longer time. They are also potential prominent drug car-
riers in the research, diagnosis and therapy of multiple dis-
eases, and are potential cancer drugs targeting on the tumor 
microenvironment. The unique property of nanomaterials 
for drug delivery and antineoplastic function highlights the 
new drug development in the future. Therefore the nano-
material biosafety needs to be assessed systematically. 
What’s more, nanotechonologies applied in basic biomedi-
cal research create a novel platform at the nano-scale to 
study and develop novel therapies for multiple diseases.  
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